The Latest Breaking News from JNJ

The economy proved resilient enough in 2023, as evidenced by recent strong economic reports. Following a brutal 2022, the S&P 500 has gotten a solid start this year and is expected to maintain the momentum. Hence, investors could consider buying fundamentally sound S&P 500 stocks Visa (V), Johnson & Johnson…

The early-year market rally witnessed a reversal, with inpouring macro data, the Fed’s hawkish comments, and recessionary fears. However, on the flip side, a bull market can still materialize with economic growth remaining strong. Therefore, we think quality stocks UnitedHealth Group (UNH), Johnson & Johnson (JNJ), and Salesforce (CRM) might…

As market uncertainties and risks obscure hopes and optimism, it could be wise to load up on shares of fundamentally sound companies, Johnson & Johnson (JNJ), AGCO Corp. (AGCO), and TravelCenters of America (TA), to help grow your portfolio over the next decade. Read on….

The stock market volatility is not expected to end anytime soon as the macroeconomic headwinds remain. So, I think fundamentally solid Johnson & Johnson (JNJ), Gilead Sciences (GILD), Stellantis (STLA), and Cardinal Health (CAH) could be the best stocks to own now and forever. Keep reading.

Healthcare giant Johnson & Johnson (JNJ) has a six-decade-long history of consecutive dividend growth. So, given the uncertainties surrounding the market, this fundamentally strong dividend-paying stock might be an ideal buy now. Read more.

With higher-than-expected job gain and inflation, concerns about the Fed’s tight monetary policy pushing the economy into a recession still loom large. Therefore, investors could look to buy fundamentally strong and profitable stocks, Johnson & Johnson (JNJ), Canon (CAJ), and Forrester Research (FORR). Keep reading….

Amid soaring concerns over an impending Fed-induced recession, the stock market could remain volatile in the near future. Against this backdrop, investors could add stable stocks Johnson & Johnson (JNJ) and Novartis (NVS) to their portfolios in 2023 to garner good returns. Read on….

With strong job growth, unexpected inflation, and robust retail sales, the Fed’s tight monetary policy could stay in place for some time. Amid volatilities and anxiety soaring, fundamentally strong stocks Johnson & Johnson (JNJ) and Cisco Systems (CSCO) might be solid portfolio additions now. Read on….

The pharma industry witnessed solid growth amid the pandemic. Moreover, with surging demand, rising investments in research and development, and increasing e-pharmacy channels, the industry is well-positioned for significant growth over the coming years. Therefore, investors could consider buying fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

As inflation is still at an alarmingly high level, the Fed is expected to continue with its rate hikes this year. However, experts see chances of the economy evading a recession. Therefore, it could be wise to buy quality stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Walmart (WMT) now…

Although favorable macro data rekindled investor optimism, the Fed’s intention of raising rates to tame stubbornly high inflation could possibly tip the economy into recession. With anxiety escalating, it would be wise to add quality stocks Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY) to your portfolio to sail through…